-
Hymon® Mycobacterium Tuberculosis Rifampin/ Isoniazid-Resistance Mutation Detection Kit
This kit uses RT-PCR for in vitro detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis in sample cultures.
Positive rpoB results: the tuberculosis is resistant to rifampicin;
Positive KatG, inhA results: the tuberculosis is resistant to isoniazid.Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® Mycobacterium Tuberculosis Detection Kit
This kit uses RT-PCR for in vitro detection of Mycobacterium tuberculosis in nasopharyngeal and/or oropharyngeal swab, sputum and bronchoalveolar lavage fluid samples. Test results may serve as a reference for clinical evaluation of Mycobacterium tuberculosis infection.
Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® COVID-19 Antigen Rapid Test Kit
Hymon® COVID-19 antigen rapid test kit is a lateral flow immunoassay for the qualitative detection of SARS-COV-2 antigen (nucleocapsid protein) with nasal swabs or saliva during the acute phase of infection. It only takes 15 minutes to complete the test and non-invasive. Negative results do not rule out SARS CoV-2 infection, and should not be used as the sole basis for treatment. Molecular assay may be performed if necessary.
